Kazunori Kubota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kazunori Kubota has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Tomoyuki Fujioka
Department of Radiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan
25 shared publications - Ukihide Tateishi
Department of Diagnostic Radiology, Institute of Science Tokyo, Tokyo 113-8510, Japan
20 shared publications - Goshi Oda
Department of Breast Surgery, Tokyo Medical and Dental University Hospital, Tokyo 113-8510, Japan
19 shared publications - Mio Mori
Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan
18 shared publications - Emi Yamaga
Department of Diagnostic Radiology and Nuclear Medicine, Institute of Science Tokyo, Tokyo, Japan
16 shared publications - Tsuyoshi Nakagawa
Department of Surgery, Breast Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan
16 shared publications
Latest Publications
- 16 April 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Chest Wall Hibernoma With Intense 18F-FDG Uptake on PET/CT Mimicking Malignant Pleural Mesothelioma
A man in his 60s with asbestos exposure and pleural plaques was incidentally found to have a chest wall mass on computed tomography (CT). Positron emission tomography/CT (PET/CT) demonstrated intense 18 F-fluorodeoxyglucose (FDG) uptake, raising concern for malignancy, including malignant pleural mesothelioma. CT and magnetic resonance imaging (MRI), however, showed a predominantly fat-containing lesion, suggesting hibernoma. Video-assisted thoracoscopic resection was performed, and histopathology confirmed hibernoma. Recognition of macroscopic fat on CT/MRI is essential to avoid misdiagnosis of FDG-avid benign lipomatous tumors.
- 16 April 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Chest Wall Hibernoma With Intense 18F-FDG Uptake on PET/CT Mimicking Malignant Pleural Mesothelioma
A man in his 60s with asbestos exposure and pleural plaques was incidentally found to have a chest wall mass on computed tomography (CT). Positron emission tomography/CT (PET/CT) demonstrated intense 18 F-fluorodeoxyglucose (FDG) uptake, raising concern for malignancy, including malignant pleural mesothelioma. CT and magnetic resonance imaging (MRI), however, showed a predominantly fat-containing lesion, suggesting hibernoma. Video-assisted thoracoscopic resection was performed, and histopathology confirmed hibernoma. Recognition of macroscopic fat on CT/MRI is essential to avoid misdiagnosis of FDG-avid benign lipomatous tumors.
- Open Access
Breast Hemangioma with Slow Growth over 11 Years: A Case Report
Background and Clinical Significance: Breast hemangioma is an extremely rare benign vascular tumor of the breast. Its imaging findings are nonspecific, and differentiation from malignant tumors such as encapsulated papillary carcinoma, mucinous carcinoma or angiosarcoma is often difficult. We report a case of breast hemangioma that showed slow growth over an 11-year period. Case Presentation: A woman in her 50s presented with a well-defined 11 mm mass in the upper outer quadrant of the left breast detected by ultrasonography. A core needle biopsy revealed a benign lesion, and follow-up was recommended. Eleven years later, the mass had increased to 27 mm. Magnetic resonance imaging showed high signal intensity on T2-weighted images and a fast-plateau enhancement pattern extending from the periphery to the center. Although malignancy was suspected, vacuum-assisted biopsy revealed a hemangioma. Conclusions: Breast hemangioma can show slow enlargement over a long period. Recognition of a characteristic peripheral-to-central enhancement pattern may aid in distinguishing this benign vascular lesion from malignant tumors.
Open AccessBreast Hemangioma with Slow Growth over 11 Years: A Case Report
Background and Clinical Significance: Breast hemangioma is an extremely rare benign vascular tumor of the breast. Its imaging findings are nonspecific, and differentiation from malignant tumors such as encapsulated papillary carcinoma, mucinous carcinoma or angiosarcoma is often difficult. We report a case of breast hemangioma that showed slow growth over an 11-year period. Case Presentation: A woman in her 50s presented with a well-defined 11 mm mass in the upper outer quadrant of the left breast detected by ultrasonography. A core needle biopsy revealed a benign lesion, and follow-up was recommended. Eleven years later, the mass had increased to 27 mm. Magnetic resonance imaging showed high signal intensity on T2-weighted images and a fast-plateau enhancement pattern extending from the periphery to the center. Although malignancy was suspected, vacuum-assisted biopsy revealed a hemangioma. Conclusions: Breast hemangioma can show slow enlargement over a long period. Recognition of a characteristic peripheral-to-central enhancement pattern may aid in distinguishing this benign vascular lesion from malignant tumors.
- 1 June 2025
- Published by Springer Nature
- p. 29-40
CRRM or Surveillance: An Evidence-Based Individual Decision-Making
- 1 June 2025
- Published by Springer Nature
- p. 29-40
CRRM or Surveillance: An Evidence-Based Individual Decision-Making
- Open Access
- 28 August 2024
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (9) , 211
AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer
Although several studies have been conducted on artificial intelligence (AI) use in mammography (MG), there is still a paucity of research on the diagnosis of metachronous bilateral breast cancer (BC), which is typically more challenging to diagnose. This study aimed to determine whether AI could enhance BC detection, achieving earlier or more accurate diagnoses than radiologists in cases of metachronous contralateral BC. We included patients who underwent unilateral BC surgery and subsequently developed contralateral BC. This retrospective study evaluated the AI-supported MG diagnostic system called FxMammo™. We evaluated the capability of FxMammo™ (FathomX Pte Ltd., Singapore) to diagnose BC more accurately or earlier than radiologists’ assessments. This evaluation was supplemented by reviewing MG readings made by radiologists. Out of 1101 patients who underwent surgery, 10 who had initially undergone a partial mastectomy and later developed contralateral BC were analyzed. The AI system identified malignancies in six cases (60%), while radiologists identified five cases (50%). Notably, two cases (20%) were diagnosed solely by the AI system. Additionally, for these cases, the AI system had identified malignancies a year before the conventional diagnosis. This study highlights the AI system’s effectiveness in diagnosing metachronous contralateral BC via MG. In some cases, the AI system consistently diagnosed cancer earlier than radiological assessments.
- 28 August 2024
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (9) , 211
Open AccessAI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer
Although several studies have been conducted on artificial intelligence (AI) use in mammography (MG), there is still a paucity of research on the diagnosis of metachronous bilateral breast cancer (BC), which is typically more challenging to diagnose. This study aimed to determine whether AI could enhance BC detection, achieving earlier or more accurate diagnoses than radiologists in cases of metachronous contralateral BC. We included patients who underwent unilateral BC surgery and subsequently developed contralateral BC. This retrospective study evaluated the AI-supported MG diagnostic system called FxMammo™. We evaluated the capability of FxMammo™ (FathomX Pte Ltd., Singapore) to diagnose BC more accurately or earlier than radiologists’ assessments. This evaluation was supplemented by reviewing MG readings made by radiologists. Out of 1101 patients who underwent surgery, 10 who had initially undergone a partial mastectomy and later developed contralateral BC were analyzed. The AI system identified malignancies in six cases (60%), while radiologists identified five cases (50%). Notably, two cases (20%) were diagnosed solely by the AI system. Additionally, for these cases, the AI system had identified malignancies a year before the conventional diagnosis. This study highlights the AI system’s effectiveness in diagnosing metachronous contralateral BC via MG. In some cases, the AI system consistently diagnosed cancer earlier than radiological assessments.
- Open Access
- 31 July 2024
- Published by MDPI AG in Preprints.org
AI Use in the Diagnosis of Mammography for Metachronous Contralateral Breast Cancer
Background: Although several studies have been conducted on the use of Artificial Intelligence (AI) in mammography (MG), research focusing on the diagnosis of metachronous bilateral breast cancer (BC), which is typically more challenging to diagnose, remains limited. This study assessed whether AI could enhance the detection of BC, achieving earlier or more accurate diagnoses than radiologists in cases of metachronous contralateral BC. Methods: The study included patients who underwent unilateral BC surgery and subsequently developed contralateral BC during follow-up. We evaluated the capability of the AI-supported MG diagnostic system FxMammo™ (FathomX Pte Ltd, Singapore) to diagnose BC more accurately or earlier than radiologists' assessments. This evaluation was supplemented by reviewing MG readings by radiologists. Results: Out of 1,101 patients who underwent surgery, 10 patients who had initially received a partial mastectomy and later developed contralateral BC were analyzed. The AI system identified malignancies in 6 cases (60%), while radiologists identified 5 cases (50%). Notably, two cases (20%) were diagnosed solely by the AI system. Additionally, for these cases, the AI system had identified malignancies a year prior to the conventional diagnosis. Conclusions: This study highlights the AI system's effectiveness in diagnosing metachronous contralateral BC via MG. In some cases, the AI system consistently diagnosed cancer at earlier than radiological assessments.
- 31 July 2024
- Published by MDPI AG in Preprints.org
Open AccessAI Use in the Diagnosis of Mammography for Metachronous Contralateral Breast Cancer
Background: Although several studies have been conducted on the use of Artificial Intelligence (AI) in mammography (MG), research focusing on the diagnosis of metachronous bilateral breast cancer (BC), which is typically more challenging to diagnose, remains limited. This study assessed whether AI could enhance the detection of BC, achieving earlier or more accurate diagnoses than radiologists in cases of metachronous contralateral BC. Methods: The study included patients who underwent unilateral BC surgery and subsequently developed contralateral BC during follow-up. We evaluated the capability of the AI-supported MG diagnostic system FxMammo™ (FathomX Pte Ltd, Singapore) to diagnose BC more accurately or earlier than radiologists' assessments. This evaluation was supplemented by reviewing MG readings by radiologists. Results: Out of 1,101 patients who underwent surgery, 10 patients who had initially received a partial mastectomy and later developed contralateral BC were analyzed. The AI system identified malignancies in 6 cases (60%), while radiologists identified 5 cases (50%). Notably, two cases (20%) were diagnosed solely by the AI system. Additionally, for these cases, the AI system had identified malignancies a year prior to the conventional diagnosis. Conclusions: This study highlights the AI system's effectiveness in diagnosing metachronous contralateral BC via MG. In some cases, the AI system consistently diagnosed cancer at earlier than radiological assessments.
- Open Access
- 29 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 727
Arterial Calcification Disappearance in Breast Imaging: A Key Indicator for Transition to Invasive Ductal Carcinoma
A woman in her 70s, initially suspected of having fibroadenoma due to a well-defined mass in her breast, underwent regular mammography and ultrasound screenings. Over several years, no appreciable alterations in the mass were observed, maintaining the fibroadenoma diagnosis. However, in the fourth year, an ultrasound indicated slight enlargement and peripheral irregularities in the mass, even though the mammography images at that time showed no alterations. Interestingly, mammography images over time showed the gradual disappearance of previously observed arterial calcification around the mass. Pathological examination eventually identified the mass as invasive ductal carcinoma. Although the patient had breast tissue arterial calcification typical of atherosclerosis, none was present around the tumor-associated arteries. This case highlights the importance of monitoring arterial calcification changes in mammography, suggesting that they are crucial indicators in breast cancer diagnosis, beyond observing size and shape alterations.
- 29 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 727
Open AccessArterial Calcification Disappearance in Breast Imaging: A Key Indicator for Transition to Invasive Ductal Carcinoma
A woman in her 70s, initially suspected of having fibroadenoma due to a well-defined mass in her breast, underwent regular mammography and ultrasound screenings. Over several years, no appreciable alterations in the mass were observed, maintaining the fibroadenoma diagnosis. However, in the fourth year, an ultrasound indicated slight enlargement and peripheral irregularities in the mass, even though the mammography images at that time showed no alterations. Interestingly, mammography images over time showed the gradual disappearance of previously observed arterial calcification around the mass. Pathological examination eventually identified the mass as invasive ductal carcinoma. Although the patient had breast tissue arterial calcification typical of atherosclerosis, none was present around the tumor-associated arteries. This case highlights the importance of monitoring arterial calcification changes in mammography, suggesting that they are crucial indicators in breast cancer diagnosis, beyond observing size and shape alterations.
- Open Access
Clinical Utility of Breast Ultrasound Images Synthesized by a Generative Adversarial Network
Background and Objectives: This study compares the clinical properties of original breast ultrasound images and those synthesized by a generative adversarial network (GAN) to assess the clinical usefulness of GAN-synthesized images. Materials and Methods: We retrospectively collected approximately 200 breast ultrasound images for each of five representative histological tissue types (cyst, fibroadenoma, scirrhous, solid, and tubule-forming invasive ductal carcinomas) as training images. A deep convolutional GAN (DCGAN) image-generation model synthesized images of the five histological types. Two diagnostic radiologists (reader 1 with 13 years of experience and reader 2 with 7 years of experience) were given a reading test consisting of 50 synthesized and 50 original images (≥1-month interval between sets) to assign the perceived histological tissue type. The percentages of correct diagnoses were calculated, and the reader agreement was assessed using the kappa coefficient. Results: The synthetic and original images were indistinguishable. The correct diagnostic rates from the synthetic images for readers 1 and 2 were 86.0% and 78.0% and from the original images were 88.0% and 78.0%, respectively. The kappa values were 0.625 and 0.650 for the synthetic and original images, respectively. The diagnoses made from the DCGAN synthetic images and original images were similar. Conclusion: The DCGAN-synthesized images closely resemble the original ultrasound images in clinical characteristics, suggesting their potential utility in clinical education and training, particularly for enhancing diagnostic skills in breast ultrasound imaging.
Open AccessClinical Utility of Breast Ultrasound Images Synthesized by a Generative Adversarial Network
Background and Objectives: This study compares the clinical properties of original breast ultrasound images and those synthesized by a generative adversarial network (GAN) to assess the clinical usefulness of GAN-synthesized images. Materials and Methods: We retrospectively collected approximately 200 breast ultrasound images for each of five representative histological tissue types (cyst, fibroadenoma, scirrhous, solid, and tubule-forming invasive ductal carcinomas) as training images. A deep convolutional GAN (DCGAN) image-generation model synthesized images of the five histological types. Two diagnostic radiologists (reader 1 with 13 years of experience and reader 2 with 7 years of experience) were given a reading test consisting of 50 synthesized and 50 original images (≥1-month interval between sets) to assign the perceived histological tissue type. The percentages of correct diagnoses were calculated, and the reader agreement was assessed using the kappa coefficient. Results: The synthetic and original images were indistinguishable. The correct diagnostic rates from the synthetic images for readers 1 and 2 were 86.0% and 78.0% and from the original images were 88.0% and 78.0%, respectively. The kappa values were 0.625 and 0.650 for the synthetic and original images, respectively. The diagnoses made from the DCGAN synthetic images and original images were similar. Conclusion: The DCGAN-synthesized images closely resemble the original ultrasound images in clinical characteristics, suggesting their potential utility in clinical education and training, particularly for enhancing diagnostic skills in breast ultrasound imaging.
- Open Access
- 11 December 2023
- Published by Springer Nature in Breast Cancer
- Vol. 31 (2) , 165
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
- 11 December 2023
- Published by Springer Nature in Breast Cancer
- Vol. 31 (2) , 165
Open AccessCorrection: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
- Open Access
- 16 November 2023
- Published by Springer Nature in Breast Cancer
- Vol. 31 (2) , 157-164
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
This article provides updates to readers based on the newly published Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2022 Edition. These guidelines incorporate the latest evaluation of evidence from studies of diagnostic accuracy. For each clinical question, outcomes for benefits and harms were established, and qualitative or quantitative systematic reviews were conducted. Recommendations were determined through voting by a multidisciplinary group, and guidelines were documented to facilitate shared decision-making among patients and medical professionals. The guidelines address screening, surveillance, and pre- and postoperative diagnosis of breast cancer. In an environment that demands an integrated approach, decisions are needed on how to utilize modalities, such as mammography, ultrasound, MRI, and PET/CT. Additionally, it is vital to understand the appropriate use of new technologies, such as tomosynthesis, elastography, and contrast-enhanced ultrasound, and to consider how best to adapt these methods for individual patients.
- 16 November 2023
- Published by Springer Nature in Breast Cancer
- Vol. 31 (2) , 157-164
Open AccessThe Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
This article provides updates to readers based on the newly published Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2022 Edition. These guidelines incorporate the latest evaluation of evidence from studies of diagnostic accuracy. For each clinical question, outcomes for benefits and harms were established, and qualitative or quantitative systematic reviews were conducted. Recommendations were determined through voting by a multidisciplinary group, and guidelines were documented to facilitate shared decision-making among patients and medical professionals. The guidelines address screening, surveillance, and pre- and postoperative diagnosis of breast cancer. In an environment that demands an integrated approach, decisions are needed on how to utilize modalities, such as mammography, ultrasound, MRI, and PET/CT. Additionally, it is vital to understand the appropriate use of new technologies, such as tomosynthesis, elastography, and contrast-enhanced ultrasound, and to consider how best to adapt these methods for individual patients.
- 27 August 2023
- Published by Springer Nature in Breast Cancer
- Vol. 33 (1) , 17-24
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images
Background Dedicated breast positron emission tomography (dbPET) has high contrast and resolution optimized for detecting small breast cancers, leading to its noisy characteristics. This study evaluated the application of deep learning to the automatic segmentation of abnormal uptakes on dbPET to facilitate the assessment of lesions. To address data scarcity in model training, we used collage images composed of cropped abnormal uptakes and normal breasts for data augmentation. Methods This retrospective study included 1598 examinations between April 2015 and August 2020. A U-Net-based model with an uptake shape classification head was trained using either the original or augmented dataset comprising collage images. The Dice score, which measures the pixel-wise agreement between a prediction and its ground truth, of the models was compared using the Wilcoxon signed-rank test. Moreover, the classification accuracies were evaluated. Results After applying the exclusion criteria, 662 breasts were included; among these, 217 breasts had abnormal uptakes (mean age: 58 ± 14 years). Abnormal uptakes on the cranio-caudal and mediolateral maximum intensity projection images of 217 breasts were annotated and labeled as focus, mass, or non-mass. The inclusion of collage images into the original dataset yielded a Dice score of 0.884 and classification accuracy of 91.5%. Improvement in the Dice score was observed across all subgroups, and the score of images without breast cancer improved significantly from 0.750 to 0.834 (effect size: 0.76, P = 0.02). Conclusions Deep learning can be applied for the automatic segmentation of dbPET, and collage images can improve model performance.
- 27 August 2023
- Published by Springer Nature in Breast Cancer
- Vol. 33 (1) , 17-24
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images
Background Dedicated breast positron emission tomography (dbPET) has high contrast and resolution optimized for detecting small breast cancers, leading to its noisy characteristics. This study evaluated the application of deep learning to the automatic segmentation of abnormal uptakes on dbPET to facilitate the assessment of lesions. To address data scarcity in model training, we used collage images composed of cropped abnormal uptakes and normal breasts for data augmentation. Methods This retrospective study included 1598 examinations between April 2015 and August 2020. A U-Net-based model with an uptake shape classification head was trained using either the original or augmented dataset comprising collage images. The Dice score, which measures the pixel-wise agreement between a prediction and its ground truth, of the models was compared using the Wilcoxon signed-rank test. Moreover, the classification accuracies were evaluated. Results After applying the exclusion criteria, 662 breasts were included; among these, 217 breasts had abnormal uptakes (mean age: 58 ± 14 years). Abnormal uptakes on the cranio-caudal and mediolateral maximum intensity projection images of 217 breasts were annotated and labeled as focus, mass, or non-mass. The inclusion of collage images into the original dataset yielded a Dice score of 0.884 and classification accuracy of 91.5%. Improvement in the Dice score was observed across all subgroups, and the score of images without breast cancer improved significantly from 0.750 to 0.834 (effect size: 0.76, P = 0.02). Conclusions Deep learning can be applied for the automatic segmentation of dbPET, and collage images can improve model performance.